4.7 Article

Low Water Intake and Risk for New-Onset Hyperglycemia

期刊

DIABETES CARE
卷 34, 期 12, 页码 2551-2554

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc11-0652

关键词

-

资金

  1. INSERM
  2. Caisse nationale de l'assurance maladie des travailleurs salaries (CNAMTS)
  3. Lilly
  4. Novartis Pharma
  5. sanofi-aventis
  6. Association Diabete Risque Vasculaire
  7. Federation Francaise de Cardiologie
  8. La Fondation de France
  9. Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)/Societe Francophone de Diabetologie
  10. L'Office national interprofessionnel des vins (ONI-VINS)
  11. Ardix Medical
  12. Bayer Diagnostics
  13. Becton Dickinson
  14. Cardionics
  15. Merck Sante
  16. Novo Nordisk
  17. Pierre Fabre
  18. Roche
  19. Topcon

向作者/读者索取更多资源

OBJECTIVE-Water intake alters vasopressin secretion. Recent findings reveal an independent association between plasma copeptin, a surrogate for vasopressin, and risk of diabetes. RESEARCH DESIGN AND METHODS-Participants were 3,615 middle-aged men and women, with normal baseline fasting glycemia (FG), who were recruited in a 9-year follow-up study. Odds ratios (ORs) and 95% CIs for the incidence of hyperglycemia (FG >= 6.1 mmol/L or treatment for diabetes) were calculated according to daily water intake classes based on a self-administered questionnaire. RESULTS-During follow-up, there were 565 incident cases of hyperglycemia. After adjustment for confounding factors, ORs (95% CIs) for hyperglycemia associated with classes of water intake (<0.5 L, n = 677; 0.5 to <1.0 L, n = 1,754; and >1.0 L, n = 1,184) were 1.00, 0.68 (0.52-0.89), and 0.79 (0.59-1.05), respectively (P = 0.016). CONCLUSIONS-Self-reported water intake was inversely and independently associated with the risk of developing hyperglycemia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据